These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 25801123
1. EphB2 activation is required for ependymoma development as well as inhibits differentiation and promotes proliferation of the transformed cell. Chen P, Rossi N, Priddy S, Pierson CR, Studebaker AW, Johnson RA. Sci Rep; 2015 Mar 24; 5():9248. PubMed ID: 25801123 [Abstract] [Full Text] [Related]
2. EphB2/R-Ras signaling regulates glioma cell adhesion, growth, and invasion. Nakada M, Niska JA, Tran NL, McDonough WS, Berens ME. Am J Pathol; 2005 Aug 24; 167(2):565-76. PubMed ID: 16049340 [Abstract] [Full Text] [Related]
3. Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Johnson RA, Wright KD, Poppleton H, Mohankumar KM, Finkelstein D, Pounds SB, Rand V, Leary SE, White E, Eden C, Hogg T, Northcott P, Mack S, Neale G, Wang YD, Coyle B, Atkinson J, DeWire M, Kranenburg TA, Gillespie Y, Allen JC, Merchant T, Boop FA, Sanford RA, Gajjar A, Ellison DW, Taylor MD, Grundy RG, Gilbertson RJ. Nature; 2010 Jul 29; 466(7306):632-6. PubMed ID: 20639864 [Abstract] [Full Text] [Related]
6. EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase. Wang SD, Rath P, Lal B, Richard JP, Li Y, Goodwin CR, Laterra J, Xia S. Oncogene; 2012 Dec 13; 31(50):5132-43. PubMed ID: 22310282 [Abstract] [Full Text] [Related]
7. Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction. Elowe S, Holland SJ, Kulkarni S, Pawson T. Mol Cell Biol; 2001 Nov 13; 21(21):7429-41. PubMed ID: 11585923 [Abstract] [Full Text] [Related]
8. The neural stem cell fate determinant TLX promotes tumorigenesis and genesis of cells resembling glioma stem cells. Park HJ, Kim JK, Jeon HM, Oh SY, Kim SH, Nam DH, Kim H. Mol Cells; 2010 Nov 13; 30(5):403-8. PubMed ID: 20814749 [Abstract] [Full Text] [Related]
9. YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis. Pajtler KW, Wei Y, Okonechnikov K, Silva PBG, Vouri M, Zhang L, Brabetz S, Sieber L, Gulley M, Mauermann M, Wedig T, Mack N, Imamura Kawasawa Y, Sharma T, Zuckermann M, Andreiuolo F, Holland E, Maass K, Körkel-Qu H, Liu HK, Sahm F, Capper D, Bunt J, Richards LJ, Jones DTW, Korshunov A, Chavez L, Lichter P, Hoshino M, Pfister SM, Kool M, Li W, Kawauchi D. Nat Commun; 2019 Sep 02; 10(1):3914. PubMed ID: 31477715 [Abstract] [Full Text] [Related]
11. Gliomagenesis arising from Pten- and Ink4a/Arf-deficient neural progenitor cells is mediated by the p53-Fbxw7/Cdc4 pathway, which controls c-Myc. Kim HS, Woolard K, Lai C, Bauer PO, Maric D, Song H, Li A, Kotliarova S, Zhang W, Fine HA. Cancer Res; 2012 Nov 15; 72(22):6065-75. PubMed ID: 22986743 [Abstract] [Full Text] [Related]
12. EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion. Sikkema AH, den Dunnen WF, Hulleman E, van Vuurden DG, Garcia-Manero G, Yang H, Scherpen FJ, Kampen KR, Hoving EW, Kamps WA, Diks SH, Peppelenbosch MP, de Bont ES. Neuro Oncol; 2012 Sep 15; 14(9):1125-35. PubMed ID: 22723427 [Abstract] [Full Text] [Related]
13. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence. Shin J, Yang J, Lee JC, Baek KH. Cell Signal; 2013 Dec 15; 25(12):2540-7. PubMed ID: 23993963 [Abstract] [Full Text] [Related]
14. Driver or passenger effects of augmented c-Myc and Cdc20 in gliomagenesis. Ji P, Zhou X, Liu Q, Fuller GN, Phillips LM, Zhang W. Oncotarget; 2016 Apr 26; 7(17):23521-9. PubMed ID: 26993778 [Abstract] [Full Text] [Related]
15. Ink4a/Arf-Dependent Loss of Parietal Cells Induced by Oxidative Stress Promotes CD44-Dependent Gastric Tumorigenesis. Seishima R, Wada T, Tsuchihashi K, Okazaki S, Yoshikawa M, Oshima H, Oshima M, Sato T, Hasegawa H, Kitagawa Y, Goldenring JR, Saya H, Nagano O. Cancer Prev Res (Phila); 2015 Jun 26; 8(6):492-501. PubMed ID: 25813526 [Abstract] [Full Text] [Related]
16. Loss of tyrosine kinase receptor Ephb2 impairs proliferation and stem cell activity of spermatogonia in culture†. N'Tumba-Byn T, Yamada M, Seandel M. Biol Reprod; 2020 Apr 15; 102(4):950-962. PubMed ID: 31836902 [Abstract] [Full Text] [Related]
17. EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma. Farshchian M, Nissinen L, Siljamäki E, Riihilä P, Toriseva M, Kivisaari A, Ala-Aho R, Kallajoki M, Veräjänkorva E, Honkanen HK, Heljasvaara R, Pihlajaniemi T, Grénman R, Peltonen J, Peltonen S, Kähäri VM. J Invest Dermatol; 2015 Jul 15; 135(7):1882-1892. PubMed ID: 25789706 [Abstract] [Full Text] [Related]
18. MicroRNA-128 promotes cell-cell adhesion in U87 glioma cells via regulation of EphB2. Lin L, Chen X, Peng X, Zhou J, Kung HF, Lin MC, Jiang S. Oncol Rep; 2013 Sep 15; 30(3):1239-48. PubMed ID: 23835497 [Abstract] [Full Text] [Related]
19. C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma. Parker M, Mohankumar KM, Punchihewa C, Weinlich R, Dalton JD, Li Y, Lee R, Tatevossian RG, Phoenix TN, Thiruvenkatam R, White E, Tang B, Orisme W, Gupta K, Rusch M, Chen X, Li Y, Nagahawhatte P, Hedlund E, Finkelstein D, Wu G, Shurtleff S, Easton J, Boggs K, Yergeau D, Vadodaria B, Mulder HL, Becksfort J, Gupta P, Huether R, Ma J, Song G, Gajjar A, Merchant T, Boop F, Smith AA, Ding L, Lu C, Ochoa K, Zhao D, Fulton RS, Fulton LL, Mardis ER, Wilson RK, Downing JR, Green DR, Zhang J, Ellison DW, Gilbertson RJ. Nature; 2014 Feb 27; 506(7489):451-5. PubMed ID: 24553141 [Abstract] [Full Text] [Related]
20. Bmi1 and cell of origin determinants of brain tumor phenotype. Dirks P. Cancer Cell; 2007 Oct 27; 12(4):295-7. PubMed ID: 17936553 [Abstract] [Full Text] [Related] Page: [Next] [New Search]